Ignite Creation Date:
2025-12-24 @ 6:43 PM
Ignite Modification Date:
2026-01-04 @ 3:43 AM
Study NCT ID:
NCT00532857
Status:
COMPLETED
Last Update Posted:
2012-01-04
First Post:
2007-09-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab
Sponsor:
Jungsil Ro
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
NCCCTS-06-235
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None